Seeking Alpha
08 Oct 2026, 12:46 UTC · 1h ago
Harrow: Q3 Needs To Prove The Turnaround Is Real
Impact · against what's priced in
HROW is currently in a 'show-me' phase where the stock price has already corrected for H1 misses. The news is neutral as the market is now simply waiting for Q3 results to prove the turnaround thesis; the catalysts mentioned are already the prerequisite for the current valuation.
- HROW+0.00
No priced-in read yet
- In context
The 20% price decline since August reflects the market's reaction to H1 revenue misses. While product tailwinds for VEVYE and IHEEZO are positive, the stock's recovery depends on hitting $100M+ revenue and positive EBITDA in Q3, which is the current binary trigger for the investment thesis.
Read from the article alone
Search tags
